The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy

NCT01208701 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Nephropathy
Cardiovascular Diseases
Diabetes Mellitus

Interventions

DRUG: Atorvastatin
DRUG: Unikalk

Sponsor

Erling Bjerregaard Pedersen